Chronic obstructive pulmonary disease: moving from symptom relief to mortality reduction
Chronic obstructive pulmonary disease (COPD) has a 3-year mortality rate up to 37%, 2-6 times higher than the general population. We present evidence supporting pharmacological therapies to improve patient life expectancy, focusing on inhaled corticosteroids (ICSs) combined with long-acting bronchod...
Saved in:
Main Authors: | Alessandro Celi (Author), Manuela Latorre (Author), Pierluigi Paggiaro (Author), Riccardo Pistelli (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Moving towards supraspinal TRPV1 receptors for chronic pain relief
by: Berrino Liberato, et al.
Published: (2010) -
Effect of Pulmonary Rehabilitation Program on Severity of Symptoms in Patients with Chronic Obstructive Pulmonary Disease
by: Sahar Khoshkesht, et al.
Published: (2015) -
Pericardial effusion predicts mortality in patients with chronic obstructive pulmonary disease
by: Can Yücel Karabay, et al.
Published: (2015) -
Activities of daily living in patients with chronic obstructive pulmonary disease with depressive symptoms
by: Rilda Carla Alves de Souza, et al.
Published: (2020) -
Mortality Predictors in Hospitalized Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD)
by: Sadhna Mankani, et al.
Published: (2022)